Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1376.574
  • -36.641-2.59%
Trading Mar 31 14:07 ET
1397.421High1355.479Low
Constituent Stocks: 10Top Rising: BLUE+26.59%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
BLUEbluebird bio
5.1651.085+26.59%3.16M16.06M4.4104.0805.4204.41050.57M50.23M9.79M9.72M+31.76%+30.43%+33.12%-38.07%-54.69%-79.17%-38.07%--32.50%LossLoss24.76%Biotechnology
AAgilent Technologies
116.355-0.335-0.29%692.37K80.24M116.595116.690117.020113.76033.17B33.06B285.10M284.12M-4.60%-5.01%-7.90%-13.39%-19.59%-19.64%-13.39%0.82%0.24%26.6926.272.79%Diagnostics & Research
VRTXVertex Pharmaceuticals
479.795-12.895-2.62%937.50K450.74M485.790492.690487.000471.500123.21B122.82B256.79M255.99M-6.24%-6.61%-0.73%+19.14%+5.38%+14.11%+19.14%--0.37%LossLoss3.15%Biotechnology
CRBUCaribou Biosciences
0.908-0.032-3.35%603.97K549.53K0.9070.9390.9400.88984.41M76.18M93.00M83.94M-11.02%-11.02%-15.18%-42.92%-51.47%-82.03%-42.92%--0.72%LossLoss5.43%Biotechnology
EDITEditas Medicine
1.165-0.085-6.80%1.38M1.61M1.2101.2501.2251.15096.67M96.26M82.98M82.62M-16.19%-17.38%-34.18%-8.27%-65.53%-84.00%-8.27%--1.67%LossLoss6.00%Biotechnology
CRSPCRISPR Therapeutics
33.970-3.020-8.16%2.79M94.69M35.57036.99035.67032.9602.91B2.86B85.77M84.34M-20.30%-20.67%-19.67%-13.69%-25.13%-50.18%-13.69%--3.31%LossLoss7.33%Biotechnology
APLSApellis Pharmaceuticals
22.015-2.255-9.29%1.05M23.64M23.67024.27023.99521.8972.76B1.85B125.52M84.23M-9.25%-12.33%-8.50%-31.01%-19.97%-63.13%-31.01%--1.25%LossLoss8.64%Biotechnology
NTLAIntellia Therapeutics
7.145-0.925-11.46%4.20M30.23M7.6708.0707.8306.980739.63M699.59M103.52M97.91M-23.25%-25.42%-24.39%-38.72%-60.28%-73.75%-38.72%--4.29%LossLoss10.53%Biotechnology
BEAMBeam Therapeutics
19.090-3.120-14.05%3.81M73.33M21.19022.21021.38018.3001.91B1.64B99.84M85.92M-20.49%-22.15%-23.94%-23.02%-18.45%-41.55%-23.02%--4.44%LossLoss13.87%Biotechnology
SGMOSangamo Therapeutics
0.670-0.150-18.30%7.45M5.35M0.7800.8200.7900.669150.53M146.59M224.71M218.82M-23.00%-33.67%-27.22%-34.32%-14.23%+10.25%-34.32%--3.40%LossLoss14.74%Biotechnology

Comments

Read more